These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33326140)

  • 1. On the trail of blood doping-microRNA fingerprints to monitor autologous blood transfusions in vivo.
    Mussack V; Wittmann G; Pfaffl MW
    Am J Hematol; 2021 Mar; 96(3):338-353. PubMed ID: 33326140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin mass and biological passport for the detection of autologous blood doping.
    Pottgiesser T; Echteler T; Sottas PE; Umhau M; Schumacher YO
    Med Sci Sports Exerc; 2012 May; 44(5):835-43. PubMed ID: 21988933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous Blood Transfusion in Sports: Emerging Biomarkers.
    Salamin O; De Angelis S; Tissot JD; Saugy M; Leuenberger N
    Transfus Med Rev; 2016 Jul; 30(3):109-15. PubMed ID: 27260108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whispers in the Blood: Leveraging MicroRNAs for Unveiling Autologous Blood Doping in Athletes.
    Hassanpour M; Salybekov AA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous Doping with Cryopreserved Red Blood Cells - Effects on Physical Performance and Detection by Multivariate Statistics.
    Malm CB; Khoo NS; Granlund I; Lindstedt E; Hult A
    PLoS One; 2016; 11(6):e0156157. PubMed ID: 27284981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood testing in sports: hematological profile of a convicted athlete.
    Schumacher YO; Schmid A; Lenz T; Keul J
    Clin J Sport Med; 2001 Apr; 11(2):115-7. PubMed ID: 11403111
    [No Abstract]   [Full Text] [Related]  

  • 9. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers.
    Mørkeberg J; Sharpe K; Belhage B; Damsgaard R; Schmidt W; Prommer N; Gore CJ; Ashenden MJ
    Scand J Med Sci Sports; 2011 Apr; 21(2):235-43. PubMed ID: 19903320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood doping: potential of blood and urine sampling to detect autologous transfusion.
    Segura J; Lundby C
    Br J Sports Med; 2014 May; 48(10):837-41. PubMed ID: 24764552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of low-volume blood withdrawal on hematological biomarkers for the athlete biological passport.
    Krumm B; Saugy JJ; Botrè F; Faiss R
    Drug Test Anal; 2024 Feb; 16(2):168-173. PubMed ID: 37303297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
    Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
    Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in hemoglobin profile reflect autologous blood transfusion misuse in sports.
    Lamberti N; Finotti A; Gasparello J; Lampronti I; Zambon C; Cosenza LC; Fabbri E; Bianchi N; Dalla Corte F; Govoni M; Reverberi R; Gambari R; Manfredini F
    Intern Emerg Med; 2018 Jun; 13(4):517-526. PubMed ID: 29572786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood doping: the flip side of transfusion and transfusion alternatives.
    Cacic DL; Hervig T; Seghatchian J
    Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepcidin as a new biomarker for detecting autologous blood transfusion.
    Leuenberger N; Barras L; Nicoli R; Robinson N; Baume N; Lion N; Barelli S; Tissot JD; Saugy M
    Am J Hematol; 2016 May; 91(5):467-72. PubMed ID: 26822428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs as biomarkers for detection of autologous blood transfusion.
    Leuenberger N; Schumacher YO; Pradervand S; Sander T; Saugy M; Pottgiesser T
    PLoS One; 2013; 8(6):e66309. PubMed ID: 23840438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered erythroid-related miRNA levels as a possible novel biomarker for detection of autologous blood transfusion misuse in sport.
    Gasparello J; Lamberti N; Papi C; Lampronti I; Cosenza LC; Fabbri E; Bianchi N; Zambon C; Dalla Corte F; Govoni M; Reverberi R; Manfredini F; Gambari R; Finotti A
    Transfusion; 2019 Aug; 59(8):2709-2721. PubMed ID: 31148196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of autologous blood transfusions in cross-country skiers.
    Berglund B; Hemmingsson P; Birgegård G
    Int J Sports Med; 1987 Apr; 8(2):66-70. PubMed ID: 3596878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
    Leuenberger N; Saugy M
    Adv Exp Med Biol; 2015; 888():401-8. PubMed ID: 26663194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.